Ad
related to: merck & co vaccines
Search results
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 5 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for ...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 5 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 29 minutes agoDiscover the latest findings on the return on investment from pharmaceutical...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 days agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 2 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 3 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs helped offset plummeting ...